Evidence map›Paper›PMID 40111017›Full record

ReviewmBio2025

Nuclear warfare: pathogen manipulation of the nuclear pore complex and nuclear functions.

Brianna Steiert, Mary M Weber

Abstract readReview
In one paragraph

Review in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Brianna SteiertDepartment of Microbiology and Immunology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.ORCID 0000-0002-7992-004X
Mary M WeberDepartment of Microbiology and Immunology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.ORCID 0000-0001-5126-2164

Funding

TRAINING IN MECHANISMS OF PARASITISMT32AI007511 · NIAID · UNIVERSITY OF IOWA · PI BUTLER, NOAH SULLIVAN, WEBER, MARY · 1996 to 2025
$8.1M
Functional characterization of Chlamydia trachomatis inclusion membrane proteins and their role in subversion of the host vesicular traffickingR01AI150812 · NIAID · UNIVERSITY OF IOWA · PI Mary Weber · 2020 to 2026
$3.5M
The role of secreted effector proteins in Chlamydia trachomatis invasionR01AI155434 · NIAID · UNIVERSITY OF IOWA · PI WEBER, MARY · 2020 to 2024
$2.5M
Development of genetic tools for overexpression and targeted mutagenesis of Orientia tsutsugamushi TPR proteinsR61AI179999 · NIAID · UNIVERSITY OF IOWA · PI Mary Weber · 2024 to 2026
$680k
NIAID NIH HHS R01 AI150812NIAID NIH HHS R01 AI155434NIAID NIH HHS R61 AI179999NIAID NIH HHS T32 AI007511
6 · The paper itself

Abstract

Viruses and bacteria exploit the nuclear pore complex (NPC) and host nuclear functions to bypass cellular barriers and manipulate essential processes. Viruses frequently engage directly with NPC components, such as nucleoporins, to enable genome import and evade immune defenses. In contrast, bacterial pathogens rely on secreted effector proteins to disrupt nuclear transport and reprogram host transcription. These strategies reflect a remarkable evolutionary convergence, with both types of pathogens targeting the NPC and nuclear functions to promote infection. This minireview explores the overlapping and unique mechanisms by which pathogens hijack the host nucleus, shedding light on their roles in disease and potential avenues for therapeutic intervention.

Indexed as

BacteriaCell NucleusHost-Pathogen InteractionsNuclear PoreNuclear WarfareVirusesActive Transport, Cell NucleusAnimalsHumansNuclear Pore Complex ProteinsNuclear Pore Complex ProteinsbacteriaeffectorNPCnucleusvirus

Identifiers

PMID40111017
PMCPMC11980394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.